Assessment of chemotherapy induced amenorrhea (CIA) in hormone receptor positive premenopausal women with breast cancer

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Volumn 3, Issue 4, 2012, Pages 97-106

  Narmadha, M P ^a   Veena, Malaikka ^a   Rajendran, N N ^a  

^a SWAMY VIVEKANANDHA COLLEGE OF PHARMACY   (India)

Author keywords

Anthracyclines; Chemotherapy induced amenorrhea; ER+ PR+ breast cancer; Taxanes

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; HORMONE RECEPTOR; TAXANE DERIVATIVE;

ADULT; AGE DISTRIBUTION; AMENORRHEA; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INCIDENCE; INDIA; MULTIPLE CYCLE TREATMENT; POSTMENOPAUSE; RETROSPECTIVE STUDY;

EID: 84874511003     PISSN: None     EISSN: 09758585     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Anderson WF, Chu KC, Chatterjee N, Brawley O, Brinton LA. J Clin Oncol 2001; 19: 18-27.
2. Bernoux A, De Cremoux P, Laine-Bidron C, Martin EC, Asselain B, Magdelenat H. Breast Cancer Res Treat 1998; 49:219-225.
3. Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM. J Clin Oncol 2003; 21(10):1973-1979.
4. Bines J, Oleske DM, Cobleigh MA. J Clin Oncol 1996; 14: 1718-1729.
5. Costa SD, Lange S, Klinga K, Merkle E, Kaufmann M. Eur J Cancer 2002; 38(10): 1329-1334.
6. Colleoni M, Gelber S, Goldhirsch A, et al. J Clin Oncol 2009; 24:1332-1341.
7. Cosimo S, Alimonti A, Ferreti G et al. Ann Oncol 2004; 15(10): 1065-1071.
8. De Laurentiis M, Cancello G, Agostino D et al. J Clin Oncol 2008; 26(1): 44-53.
9. Fisher B, Jeong JH, Bryant J, Anderson S, Dignam J, Fisher ER, Wolmark N. Lancet 2004; 364 (9437): 858-868.
10. Francoise Clavel-Chapelon Clavel and Gerber. Breast Cancer Res Treat 2002; 72(2): 107-15
11. Ferguson T, Wilcken N, Vagg V et al. Cochrane database of systematic reviews 2002; 4. :Art no. CD004421.doi: 10.1002/14651858.CD004421.pub2.
12. Hye-Suk H, Jungsil R, Keun S, Byung- Ho N, Jung Ae S, Dae Hee L, Honggi L, Eun Sook L, Han Sung K, Seok Won K. Breast Cancer Res Treat 2009; 115: 335-342.
13. José A, Susana R, Elisa G, Esther J, Paloma M, Begoña B, Isabel C, Cecilia G, Ana L. Breast Cancer Research and Treatment 2009; 120 (1): 245-251.
14. Lisa KD, Mary AR, Christopher IL et al. Breast Cancer Research 2006; 9:R6
15. Mathews TJ, Hamilton BE. Natl Vital Stat Rep 2002; 51: (1): 1-16.
16. Padmanabhan N, Howell A, Rubens RD. Lancet 1986; 2(8504): 411-14.
17. Parkin, DM, Bray F, Ferlay J, Pisani, P. Int J Cancer 2001; 94: 153-156.
18. Parulekhar WR, Day AG, Ottaway JA et al. J Clin Oncol 2005; 23(25): 6002-6008.
19. Pichon MF, Broet P, Magdelenat H, Delarue JC, et al. Br J Cancer 1996; 73(12):1545-1551.
20. Smith RE, Good BC. Endocr Relat Cancer 2003; 10: 347-357.
21. Swain SM, Land SR, Ritter MW et al. Breast Cancer Res Treat 2009; 113: 315-320.
22. Vanhuyse M, Fournier C, Bonneterre J. Ann Oncol 2005; 16: 1283-1288.